NewsPR Newswire
Evogene Schedules Third Quarter 2026 Financial Results Release
· Published
Article summary
Zoom conference call scheduled for November 19, 2026, 9:00 AM ET REHOVOT, Israel, Nov. 5, 2026 — Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and...
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…


Comments —
Loading comments…